Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma

Introduction Primary Mediastinal Large B Cell Lymphoma (PMLBCL) is a rare but aggressive B-cell lymphoma. This study compares the outcomes and toxicities of DA-EPOCH-R (Dose-adjusted etoposide, prednisolone, vincristine, cyclophosphamide, and doxorubicin in combination with rituximab) and RCHOP-21 (...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mohammad Ma'koseh, Abeer Yaseen, Nebras Abu Abed, Omar Shahin, Alaa Abufara, Khalid Halahleh, Mohammad Al-Rwashdeh, Zaid Abdel Rahman, Ro’a Muqbel, Heba Farfoura, Akram Al-Ibraheem, Kamal Al-rabi, Hikmat Abdel-Razeq
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2025-12-01
Serija:	Hematology
Teme:	Mediastinal large B-cell lymphoma DA-EPOCH-R RCHOP Radiotherapy aa-IPI relapse
Online dostop:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2515337
Oznake:	Označite Brez oznak, prvi označite!